Alamar Biosciences, Inc.·4

Apr 20, 8:34 PM ET

Chen Shiping 4

Research Summary

AI-generated summary

Updated

Alamar Biosciences (ALMR) COO Chen Shiping Converts Derivatives, Receives RSUs

What Happened

  • Chen Shiping, Chief Operating Officer of Alamar Biosciences (ALMR), reported multiple non‑cash transactions dated April 16–20, 2026. The filing shows conversions of derivative securities into common stock and the receipt of restricted stock unit (RSU) awards. Reported activity includes acquisitions and dispositions that appear to reflect reclassifications/conversions rather than open‑market trades — all reported at $0.00 or N/A.
  • Key reported amounts (per the Form 4): several conversion and reclassification entries totaling roughly 1.63 million shares acquired and roughly 1.53 million shares disposed (many entries pair a derivative disposal with an acquisition of common shares). Reported RSU grants include 163,358 (derivative RSU grant on 4/16) and 37,220 shares (4/20). No cash changed hands in the reported transactions.

Key Details

  • Dates & prices: Transactions dated April 16 and April 20, 2026; most entries reported at $0.00 or N/A, indicating non‑cash conversions/awards.
  • Transaction types: Codes include C = conversion of derivative security, A = grant/award (RSUs), J = other acquisition/disposition (used here for reclassifications).
  • Shares owned after transaction: Not specified in the summary provided.
  • Notable footnotes from the filing:
    • F1–F3: Describes automatic conversion/reclassification of Class A, Founders Preferred, Series A‑1 Preferred and Class B shares into the common stock around the IPO (mechanical recapitalization).
    • F4: RSUs vest monthly from grant date, subject to continued service.
    • F5–F7: Describe vesting schedules for various option grants (monthly/annual vesting schedules).
  • Filing timeliness: Form 4 was filed April 20, 2026 and reports transactions dated April 16–20; no late‑filing flag is indicated in the provided data.

Context

  • These entries appear to be corporate conversions and award vesting/reclassification tied to the IPO and equity plan mechanics (not open‑market buys or cash sales). Zero‑dollar and N/A lines commonly mean conversion of previously held preferred/other share classes into common stock or issuance of RSUs, not an indication of a cash purchase or sale.
  • For retail investors: such mechanical conversions and RSU grants are routine following IPOs or capital structure changes and do not necessarily signal a change in insider sentiment.